This trial evaluates a new continuous glucose monitoring (CGM) system in adults with type 1 diabetes. Participants will wear the sensor for 14 days while their blood sugar is measured against standard lab tests to see how accurate and safe the device is across different glucose l…
Phase: NA • Sponsor: SiBionics, Co, Ltd • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC